Clearside Biomedical Stock (NASDAQ:CLSD)


RevenueOwnershipFinancialsChartTranscripts

Previous Close

$1.03

52W Range

$0.92 - $2.12

50D Avg

$1.19

200D Avg

$1.26

Market Cap

$79.64M

Avg Vol (3M)

$765.87K

Beta

2.33

Div Yield

-

CLSD Company Profile


Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase 1/2a clinical trial; and CLS-301, an integrin inhibitor suspension for the treatment of diabetic macular edema and macular degeneration. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

30

IPO Date

Jun 02, 2016

Website

CLSD Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 23Dec 22Dec 21
License$8.20M$1.30M-
Other Agreement--$13.00K

Fiscal year ends in Dec 23 | Currency in USD

CLSD Financial Summary


Dec 23Dec 22Dec 21
Revenue$8.23M$1.33M$29.57M
Operating Income$-24.84M$-30.28M$-627.00K
Net Income$-32.48M$-34.07M$376.00K
EBITDA$-24.78M$-29.61M$-449.00K
Basic EPS$-0.53$-0.57$0.01
Diluted EPS$-0.53$-0.57$0.01

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q3 24Nov 12, 24 | 8:37 PM
Q1 24May 09, 24 | 12:00 AM
Q4 23Mar 13, 24 | 12:47 AM

Peer Comparison


TickerCompany
GRCLGracell Biotechnologies Inc.
NUVBNuvation Bio Inc.
NXTCNextCure, Inc.
EWTXEdgewise Therapeutics, Inc.
TNYATenaya Therapeutics, Inc.
ERASErasca, Inc.
SNSESensei Biotherapeutics, Inc.
INBXInhibrx Biosciences, Inc.
GBIOGeneration Bio Co.
OCULOcular Therapeutix, Inc.
GRPHLENZ Therapeutics, Inc.
KRONKronos Bio, Inc.
INZYInozyme Pharma, Inc.
ORICORIC Pharmaceuticals, Inc.
CCCCC4 Therapeutics, Inc.
GLUEMonte Rosa Therapeutics, Inc.
EYENEyenovia, Inc.
DSGNDesign Therapeutics, Inc.
DRTSAlpha Tau Medical Ltd.
EPIXESSA Pharma Inc.
LYRALyra Therapeutics, Inc.
MACKMerrimack Pharmaceuticals, Inc.